Loss of glymphatic homeostasis in heart failure - Scorecard - MDSpire

Loss of glymphatic homeostasis in heart failure

  • By

  • Marios Kritsilis

  • Lotte Vanherle

  • Marko Rosenholm

  • René in ‘t Zandt

  • Yuan Yao

  • Kelley M Swanberg

  • Pia Weikop

  • Michael Gottschalk

  • Nagesh C Shanbhag

  • Jiebo Luo

  • Kimberly Boster

  • Maiken Nedergaard

  • Anja Meissner

  • Iben Lundgaard

  • December 18, 2024

  • 0 min

Share

Clinical Scorecard: Disruption of Glymphatic Function in Heart Failure Conditions

At a Glance

CategoryDetail
ConditionHeart failure with reduced ejection fraction and its impact on brain glymphatic function
Key MechanismsReduced cerebral blood flow, altered cerebral arterial pulsatility, dysregulated brain fluid dynamics affecting glymphatic influx and clearance
Target PopulationPatients with heart failure, particularly post-myocardial infarction with reduced ejection fraction
Care SettingCardiovascular and neurological clinical settings focusing on heart failure and cognitive decline management

Key Highlights

  • Heart failure leads to increased glymphatic influx but impaired clearance of proteins from brain parenchyma.
  • Cerebral arterial pulsatility is potentiated post-myocardial infarction, influencing glymphatic influx.
  • Cerebral blood flow correlates with brain clearance, highlighting its regulatory role in glymphatic function.

Guideline-Based Recommendations

Diagnosis

  • Consider assessment of cerebral blood flow and glymphatic function in patients with heart failure to evaluate risk of cognitive decline.

Management

  • Target interventions to improve cerebral blood flow may support glymphatic clearance and potentially mitigate neurodegenerative progression in heart failure.

Monitoring & Follow-up

  • Monitor cognitive function and cerebral blood flow parameters in heart failure patients, especially post-myocardial infarction.

Risks

  • Impaired glymphatic clearance due to heart failure may increase risk of neurodegeneration and Alzheimer’s disease.

Patient & Prescribing Data

Heart failure patients with reduced ejection fraction post-myocardial infarction

No direct pharmacological treatments targeting glymphatic dysfunction are described; focus is on cardiovascular management to preserve cerebral blood flow and brain clearance mechanisms.

Clinical Best Practices

  • Recognize the link between heart failure-induced cerebral hypoperfusion and glymphatic dysfunction.
  • Incorporate cerebral blood flow evaluation in the neurological assessment of heart failure patients.
  • Support research and clinical monitoring of brain clearance pathways to prevent cognitive decline in cardiovascular disease.

References

Original Source(s)

Related Content